Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva Execs Topped TASE's High Earners List for 2018 | Ctech
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO | InvestorPlace
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
23 Teva Pharmaceuticals Open New Logistic Centre In Israel Photos and Premium High Res Pictures - Getty Images
Teva Pharmaceuticals appoints Richard Francis CEO | HealthCare Middle East & Africa Magazine
Teva CEO stands down during troubled times - MedCity News
Kåre Schultz - Wikipedia
Teva Pharmaceuticals Appoints Richard Francis CEO | Contract Pharma
Teva's New CEO Francis Takes Over A Steadier – Though Still Rocky – Organization :: Scrip
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceuticals Appoints Richard Francis CEO | Contract Pharma
Sol Barer elected chairman of Israel's Teva Pharmaceuticals - NJBIZ
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva CEO exits amid crisis of confidence at drugmaker | Fox Business
Eli Hurvitz, Founder of Teva Pharmaceutical Industries, Dies at 79 - The New York Times
Teva CEO reportedly wanted to stay in his job | The Times of Israel
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva Pharmaceutical CEO Talks Opioids, Lawsuits, and the Long Road Ahead | Barron's
Teva buys Anda for $500 million - ISRAEL21c
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha
